#carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

Limiter la propagation. Améliorer les résultats.

Chaque fois qu’un micro-organisme devient résistant à un antibiotique, nous perdons une nouvelle arme vitale dans la lutte contre l’infection. Chaque jour, de nouveaux micro-organismes résistants font leur apparition et se répandent dans le monde. Résultat : antimicrobial resistance (AMR). In the very near future, we may be left without any drugs at all to fight serious, resistant infections.⁷

Antimicrobial resistance (AMR) leads to longer hospital stays, increased mortality, and higher medical costs.

AMR is one of the top 10 global public health threats facing humanity, with misuse and overuse of antimicrobials being the main drivers in the development of drug-resistant pathogens. In addition to death and disability, prolonged illness results in longer hospital stays and financial challenges for those impacted.¹

Why AMR Matters:

2,8 Million
infections annually¹

35 000
deaths annually in the U.S.²

4,6 Billion
in extra healthcare costs³

Relationship to Healthcare-Associated Infections (HAIs)^4,5

HAIs are frequently caused by drug-resistant bacteria. HAIs can:

1 in 3
bacteria associated with HAIs are resistant to antibiotics⁴

4,5 Million
annual number of patients with at least one HAI⁵

1 in 15
number of patients on any given day with at least one HAI⁴

Everyone is at Risk⁶

Some, however, are high-risk and disproportionally impacted:

Patients undergoing cancer therapy

Patients with weakened immune systems

Patients undergoing dialysis

Patients undergoing complex surgery

#carousel-content-10 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-10 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

VIDÉO

What is "The Antibiotic Apocalypse"?

L’apocalypse antibiotique. Elle est plus dangereuse que ce que nous pensions.

Visionner la vidéo

How We Can Build Better Antibiotic Stewardship with the GeneXpert^® System

With on-demand molecular diagnostics, today’s healthcare providers are able to quickly identify whether an infection is present and if it is drug-resistant, in minutes, rather than days. Cepheid’s GeneXpert^® system helps those on the frontlines of resistance prevent the inappropriate use of antimicrobials and preserve our antibiotic weapons―now and in the future. For more information, download our antimicrobial stewardship brochure.

Download AMR Infographic Brochure

#carousel-content-12 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-12 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

VIDÉO

Antibiotics "just-in-case" | Debbie Goff | TEDxColumbus

In a recent TEDx talk, Dr. Debbie Goff, a clinical pharmacist and global antimicrobial stewardship advocate, outlined a compelling case for shared accountability in the fight against drug-resistant organisms. With real-life examples of “just in case” antibiotic use, the case for stewardship is presented with impressive clarity and humanity.

Visionner la vidéo

VIDÉO

Carbapénémases

Le Dr Tim Neal, médecin spécialiste de la lutte contre les infections chez Liverpool Clinical Laboratories, explique en quoi les solutions de diagnostic moléculaire rapide sont essentielles pour devancer la menace émergente des entérobactéries productrices de carbapénémases (EPC).

Read the related white paper

Visionner la vidéo

Livres blancs et webinaires connexes

#carousel-content-13 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-13 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

WEBINAIRE

Du bon usage des antibiotiques aux Urgences

Ce webinaire traite de l’importance du bon usage des antimicrobiens et de la précision des tests diagnostiques pour détecter les pharyngites à streptocoques du groupe A. Il fournit des informations sur la grande confiance que permettent les tests moléculaires pour le bon usage des antibiotiques et explique comment la technologie permet de réduire l’habitude de prescrire des antibiotiques « juste au cas où », en présence d’une infection, en particulier lorsque les tests ont lieu plus près des patients.

WEBINAIRE

RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs

This webinar discusses data supporting the combination of rapid diagnostic tests (RDT) and antimicrobial stewardship programs (ASPs), reviews RDT systems, and provides guidance on how ASPs can implement and optimize the use of RDTs in virtually any healthcare setting.

DOCUMENT

White Paper: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance

CDC has declared the complex problem of AMR a serious threat today, which will result in potential catastrophic consequences with continued inaction. To combat AMR, the CDC has identified 4 core actions, all of which can be addressed through rapid molecular diagnostics:

DOCUMENT

White Paper: Preventing "Nightmare Bacteria" from Becoming Nightmare Outbreaks

In early 2015, carbapenem-resistant Enterobacteriaceae (CRE) became a household term when a high-profile outbreak — including two deaths — at a California hospital were linked to contaminated medical scopes.

Lien vers les produits connexes

#carousel-content-14 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-14 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

Xpert^® Carba-R

Xpert^®Carba-R est un test qualitatif de PCR en temps réel à la demande pour la détection et la différenciation de KPC, NDM, VIM, OXA-48 et IMP en 48 minutes